New MRI technique could predict MS therapy success
NCT ID NCT07510607
First seen Apr 06, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study involves 40 adults with relapsing-remitting multiple sclerosis (MS) who have not taken disease-modifying treatments in the last two years. Researchers will use a special MRI scan to measure metabolic changes in the brain before and after starting anti-CD20 therapy. The goal is to see if this imaging method can predict how well patients respond to treatment and help monitor brain inflammation without invasive procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Byers Hall
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.